LBRX
LB Pharmaceuticals Inc
34.60$
-6.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +66.7% | +1,500.0% | -1.2% | -3.8% | +6.6% | +4.9% | -3.5% | +18.3% | – | |
| – | +364.4% | +39.2% | +382.4% | -72.2% | -47.2% | +163.0% | +165.7% | +9.6% | +91.0% | – | |
| – | +54.5% | -201.9% | – | – | – | – | – | – | – | – | |
| – | -12.8% | +980.5% | -46.3% | -91.2% | -57.1% | -100.0% | – | -20.0% | +1,034.4% | – | |
| – | – | +319.3% | – | – | -99.8% | -498,277.8% | -99.9% | -20.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | +566.7% | -100.0% | – | – | – | -100.4% | – | -100.0% | – | |
| – | -434.8% | – | +14.8% | -140.0% | – | – | -107.7% | – | -153.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.